Does the location of inflammatory lesions in the gastrointestinal tract determine the clinical course of Crohn’s disease?

[1] Arora U., Kedia S., Garg S., Bopanna S., Jain S., Yadav D.P., Goyal S., Gupta V., Sahni P., Pal S., Dash N.R., Madhusudhan K.S., Sharma R., Makharia G., Ahuja V.: Colonic Crohn’s disease is associated with less aggressive disease course than ileal or ileocolonic disease. Dig. Dis. Sci., 2018; 63: 1592–1599 AroraU. KediaS. GargS. BopannaS. JainS. YadavD.P. GoyalS. GuptaV. SahniP. PalS. DashN.R. MadhusudhanK.S. SharmaR. MakhariaG. AhujaV. Colonic Crohn’s disease is associated with less aggressive disease course than ileal or ileocolonic disease Dig. Dis. Sci. 2018 63 1592 1599 10.1007/s10620-018-5041-4 Search in Google Scholar

[2] Bartnik W.: Choroba Crohna jelita grubego. Pol. Arch. Med. Wewn., 1971; 47: 383–388 BartnikW. Choroba Crohna jelita grubego Pol. Arch. Med. Wewn. 1971 47 383 388 Search in Google Scholar

[3] Bartnik W.: Inflammatory bowel disease – polish contribution. J. Physiol. Pharmacol. 2003; 54 Suppl., 3: 205–210 BartnikW. Inflammatory bowel disease – polish contribution J. Physiol. Pharmacol. 2003 54 Suppl. 3 205 210 Search in Google Scholar

[4] Cleynen I., Boucher G., Jostins L., Schumm P., Zeissig S., Ahmad T., Andersen V., Andrews J.M., Annese V., Brand S., Brant S.R., Cho J.C., Daly M.J., Dubinsky M., Duerr R.H., et al.: International Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: A genetic association study. Lancet, 2016; 387: 156–167 CleynenI. BoucherG. JostinsL. SchummP. ZeissigS. AhmadT. AndersenV. AndrewsJ.M. AnneseV. BrandS. BrantS.R. ChoJ.C. DalyM.J. DubinskyM. DuerrR.H. International Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: A genetic association study Lancet 2016 387 156 167 10.1016/S0140-6736(15)00465-1 Search in Google Scholar

[5] Cleynen I., González J.R., Figueroa C., Franke A., McGovern D., Bortlík M., Crusius B.JA., Vecchi M., Artieda M., Szczypiorska M., Bethge J., Arteta D., Ayala E., Danese S., Hogezand R., et al.: Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBD European Project. Gut, 2013; 62: 1556–1565 CleynenI. GonzálezJ.R. FigueroaC. FrankeA. McGovernD. BortlíkM. CrusiusB.JA. VecchiM. ArtiedaM. SzczypiorskaM. BethgeJ. ArtetaD. AyalaE. DaneseS. HogezandR. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBD European Project Gut 2013 62 1556 1565 10.1136/gutjnl-2011-300777 Search in Google Scholar

[6] Crohn B.B., Ginzburg L., Oppenheimer G.D.: Regional ileitis; a pathologic and clinical entity. JAMA, 1932; 99; 1323–1329 CrohnB.B. GinzburgL. OppenheimerG.D. Regional ileitis; a pathologic and clinical entity JAMA 1932 99 1323 1329 10.1001/jama.1932.02740680019005 Search in Google Scholar

[7] Daperno M., D’Haens G., Van Assche G., Baert F., Bulois P., Maunoury V., Sostegni R., Rocca R., Pera A., Gevers A., Mary Y.V., Colombel J.F., Rutgeerts P.: Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest. Endosc., 2004; 60: 505–512 DapernoM. D’HaensG. Van AsscheG. BaertF. BuloisP. MaunouryV. SostegniR. RoccaR. PeraA. GeversA. MaryY.V. ColombelJ.F. RutgeertsP. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD Gastrointest. Endosc. 2004 60 505 512 10.1016/S0016-5107(04)01878-4 Search in Google Scholar

[8] Dulai P.S., Singh S., Casteele N.V., Boland B.S., Rivera-Nieves J., Ernst P.B., Eckmann L., Barrett K.E., Chang J.T., Sandborn W.J.: Should we divide Crohn’s disease into ileum-dominant and isolated colonic diseases? Clin. Gastroenterol. Hepatol., 2019; 17: 2634–2643 DulaiP.S. SinghS. CasteeleN.V. BolandB.S. Rivera-NievesJ. ErnstP.B. EckmannL. BarrettK.E. ChangJ.T. SandbornW.J. Should we divide Crohn’s disease into ileum-dominant and isolated colonic diseases? Clin. Gastroenterol. Hepatol. 2019 17 2634 2643 10.1016/j.cgh.2019.04.040688545331009791 Search in Google Scholar

[9] Fiocchi C.: Inflammatory bowel disease pathogenesis: Where are we? J. Gastroenterol. Hepatol., 2015; 30, Suppl. 1: 12–28 FiocchiC. Inflammatory bowel disease pathogenesis: Where are we? J. Gastroenterol. Hepatol. 2015 30 Suppl. 1 12 28 10.1111/jgh.1275125827798 Search in Google Scholar

[10] Guizzetti L., Zou G., Khanna R., Dulai P.S., Sandborn W.J., Jairath V., Feagan B.G.: Development of clinical prediction models for surgery and complications in Crohn’s disease. J. Crohns. Colitis, 2018; 12: 167–177 GuizzettiL. ZouG. KhannaR. DulaiP.S. SandbornW.J. JairathV. FeaganB.G. Development of clinical prediction models for surgery and complications in Crohn’s disease J. Crohns. Colitis 2018 12 167 177 10.1093/ecco-jcc/jjx130588174629028958 Search in Google Scholar

[11] Hancock L., Beckly J., Geremia A., Cooney R., Cummings F., Pathan S., Guo C., Warren B., Mortensen N., Ahmad T., Jewell D.: Clinical and molecular characteristics of isolated colonic Crohn’s disease. Inflamm. Bowel Dis., 2008; 14: 1667–1677 HancockL. BecklyJ. GeremiaA. CooneyR. CummingsF. PathanS. GuoC. WarrenB. MortensenN. AhmadT. JewellD. Clinical and molecular characteristics of isolated colonic Crohn’s disease Inflamm. Bowel Dis. 2008 14 1667 1677 10.1002/ibd.2051718521924 Search in Google Scholar

[12] Li D., Haritunians T., Landers C., Potdar A.P., Yang S., Huang H., Schumm P., Daly M., Targan S., McGovern D.: Late-onset Crohn’s disease is a subgroup distinct in genetic and behavioral risk factors with UC-like characteristics. Inflamm. Bowel Dis., 2018; 24: 2413–2422 LiD. HarituniansT. LandersC. PotdarA.P. YangS. HuangH. SchummP. DalyM. TarganS. McGovernD. Late-onset Crohn’s disease is a subgroup distinct in genetic and behavioral risk factors with UC-like characteristics Inflamm. Bowel Dis. 2018 24 2413 2422 10.1093/ibd/izy148619517529860388 Search in Google Scholar

[13] Lockhart-Mummery H.E., Morson B.C.: Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut, 1960; 1: 87–105 Lockhart-MummeryH.E. MorsonB.C. Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis Gut 1960 1 87 105 10.1136/gut.1.2.87141321714417801 Search in Google Scholar

[14] Łodyga M., Eder P., Bartnik W., Gonciarz M., Kłopocka M., Linke K., Małecka-Panas E., Radwan P., Rydzewska G.: Guidelines for the management of Crohn’s disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology. Gastroenterology Rev., 2013; 7: 317–338 ŁodygaM. EderP. BartnikW. GonciarzM. KłopockaM. LinkeK. Małecka-PanasE. RadwanP. RydzewskaG. Guidelines for the management of Crohn’s disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology Gastroenterology Rev. 2013 7 317 338 10.5114/pg.2012.33040 Search in Google Scholar

[15] Mulder D.J., Noble A.J., Justinich C.J., Duffin J.M.: A tale of two diseases: The history of inflammatory bowel disease. J. Crohns Colitis, 2014; 8: 341–348 MulderD.J. NobleA.J. JustinichC.J. DuffinJ.M. A tale of two diseases: The history of inflammatory bowel disease J. Crohns Colitis 2014 8 341 348 10.1016/j.crohns.2013.09.00924094598 Search in Google Scholar

[16] Parkes G.C., Whelan K., Lindsay J.O.: Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J. Crohns Colitis, 2014; 8: 717–725 ParkesG.C. WhelanK. LindsayJ.O. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect J. Crohns Colitis 2014 8 717 725 10.1016/j.crohns.2014.02.00224636140 Search in Google Scholar

[17] Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Löfberg R., Modigliani R., Present D.H., Rutgeerts P., Schölmerich J., Stange E.F., Sutherland L.R.: A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology, 2002; 122: 512–530 SandbornW.J. FeaganB.G. HanauerS.B. LochsH. LöfbergR. ModiglianiR. PresentD.H. RutgeertsP. SchölmerichJ. StangeE.F. SutherlandL.R. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease Gastroenterology 2002 122 512 530 10.1053/gast.2002.3107211832465 Search in Google Scholar

[18] Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F.: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 2006; 55: 749–753 SatsangiJ. SilverbergM.S. VermeireS. ColombelJ.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications Gut 2006 55 749 753 10.1136/gut.2005.082909185620816698746 Search in Google Scholar

[19] Solberg I.C., Cvancarova M., Vatn M.H., Moum B.: Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn’s disease. Inflamm. Bowel Dis., 2014; 20: 60–68 SolbergI.C. CvancarovaM. VatnM.H. MoumB. Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn’s disease Inflamm. Bowel Dis. 2014 20 60 68 10.1097/01.MIB.0000436956.78220.6724280875 Search in Google Scholar

[20] Solberg I.C., Vatn M.H., Hřie O., Stray N., Sauar J., Jahnsen J., Moum B., Lygren I.: Clinical course in Crohn’s disease: Results of a Norwegian population based ten-year follow-up study. Clin. Gastroenterol. Hepatol., 2007; 5: 1430–1438 SolbergI.C. VatnM.H. HřieO. StrayN. SauarJ. JahnsenJ. MoumB. LygrenI. Clinical course in Crohn’s disease: Results of a Norwegian population based ten-year follow-up study Clin. Gastroenterol. Hepatol. 2007 5 1430 1438 10.1016/j.cgh.2007.09.00218054751 Search in Google Scholar

[21] Subramanian S., Ekbom A., Rhodes J.M.: Recent advances in clinical practice: A systematic review of isolated colonic Crohn’s disease: The third IBD? Gut, 2017; 66: 362–381 SubramanianS. EkbomA. RhodesJ.M. Recent advances in clinical practice: A systematic review of isolated colonic Crohn’s disease: The third IBD? Gut 2017 66 362 381 10.1136/gutjnl-2016-31267327802156 Search in Google Scholar

[22] Wells C.: Ulcerative colitis and Crohn’s disease. Ann. R. Coll. Surg. Engl., 1952; 11: 105–120 WellsC. Ulcerative colitis and Crohn’s disease Ann. R. Coll. Surg. Engl. 1952 11 105 120 10.2307/585934 Search in Google Scholar

[23] Xu Y., Guo Z., Cao L., Xie T., Shen W., Li Y., Gong J., Zhu W.: Isolated colonic Crohn’s disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease. Clin. Nutr., 2019; 38: 1629–1635 XuY. GuoZ. CaoL. XieT. ShenW. LiY. GongJ. ZhuW. Isolated colonic Crohn’s disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease Clin. Nutr. 2019 38 1629 1635 10.1016/j.clnu.2018.08.02230193873 Search in Google Scholar

[24] Zhang Y.Z., Li Y.Y.: Inflammatory bowel disease: Pathogenesis. World J. Gastroenterol., 2014; 20: 91–99 ZhangY.Z. LiY.Y. Inflammatory bowel disease: Pathogenesis World J. Gastroenterol. 2014 20 91 99 10.3748/wjg.v20.i1.91388603624415861 Search in Google Scholar